Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
BJS Open|November 5, 2025
One-stage versus two-stage surgery for initially unresectable colorectal cancer liver metastases: post hoc analysis of the CAIRO5 trialMarinde J G Bond, Karen Bolhuis, Martinus J van Amerongen, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic TreatmentNina J Wesdorp, Karen Bolhuis, Joran Roor, et al.
Annals of Surgical Oncology|April 28, 2023
Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer GroupMarinde J G Bond, Babette I Kuiper, Karen Bolhuis, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 25, 2018
Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide auditLennart B van Rijssen, Maurice J Zwart, Susan van Dieren, et al.
Cardiovascular and Interventional Radiology|March 2, 2022
Study Protocol PROMETHEUS: Prospective Multicenter Study to Evaluate the Correlation Between Safety Margin and Local Recurrence After Thermal Ablation Using Image Co-registration in Patients with Hepatocellular CarcinomaTimo T M Oosterveer, Gonnie C M van Erp, Pim Hendriks, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trialKaren Bolhuis, Marinde J G Bond, Martin J Van Amerongen, et al.
JAMA Oncology|November 21, 2024
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical TrialMarinde J G Bond, Karen Bolhuis, Olaf J L Loosveld, et al.
The Lancet. Oncology|June 17, 2023
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J G Bond, Karen Bolhuis, Olaf J L Loosveld, et al.
European Radiology Experimental|December 1, 2023
Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastasesNina J Wesdorp, J Michiel Zeeuw, Sam C J Postma, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Pageof 12